Randall Stanicky analyst

Currently out of the existing stock ratings of Randall Stanicky, 151 are a BUY (64.26%), 78 are a HOLD (33.19%), 6 are a SELL (2.55%).

Randall Stanicky

Work Performance Price Targets & Ratings Chart

Analyst Randall Stanicky, carries an average stock price target met ratio of 45.27% that have a potential upside of 38.9% achieved within 378 days. Previously, Randall Stanicky worked at RBC, CANACCORD.

Randall Stanicky’s has documented 459 price targets and ratings displayed on 28 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ENDP, Endo International PLC at 07-Apr-2021.

Wall Street Analyst Randall Stanicky

Analyst best performing recommendations are on AGRX (AGILE THRPE).
The best stock recommendation documented was for AGRX (AGILE THRPE) at 10/31/2019. The price target of $4000 was fulfilled within 5 days with a profit of $1600 (66.67%) receiving and performance score of 133.33.

Average potential price target upside

ABBV AbbVie ACRX AcelRx Pharmaceuticals AGN Allergan plc AGRX Agile Thrpe AKRX Akorn AMRX Amneal Pharmaceuticals, Common Stock EGRX Eagle Pharmaceuticals ENDP Endo International PLC FLXN Flexion Therapeutics INSY INSYS Therapeutics JAZZ Jazz Pharmaceuticals PLC KMPH KemPharm MRK Merck mpany MYL Viatris OSMT Osmotica Pharmaceuticals plc PCRX Pacira Pharmaceuticals PFE Pfizer PRGO Perrigo Company PLC SGNT Sagent Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR VTRS Viatris XERS Xeris Pharmaceuticals AQST Aquestive Therapeutics ASRT Assertio Therapeutics NEOS Neos Therapeutics OPTN OptiNose RVLP RVL Pharmaceuticals PLC OS OneStream, Common Stock

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2026

$315

$57.88 (22.51%)

$265

Buy Since 12-Sep-2025

$303

$45.88 (17.84%)

$298

27 days ago
(20-Aug-2026)

2/8 (25%)

$41.17 (15.72%)

35

Buy Since 08-Dec-2021

$300

$42.88 (16.68%)

$295

30 days ago
(17-Aug-2026)

9/11 (81.82%)

$49.67 (19.84%)

469

Buy Since 23-Jan-2023

$260

$2.88 (1.12%)

$235

1 months 6 days ago
(10-Aug-2026)

9/9 (100%)

$12.03 (4.85%)

127

Buy Since 06-Feb-2020

$288

$30.88 (12.01%)

$261

1 months 12 days ago
(04-Aug-2026)

36/37 (97.3%)

$44.2 (18.13%)

434

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?